絞り込み

17799

広告

新型コロナ 寮の部員ら88人感染 松江の高校サッカー部 (毎日新聞)

松江市で新型コロナウイルスへの感染が明らかになった91人について、市と島根県は9日夜、88人が立正大淞南(しょうなん)高校(北村直樹校長、生徒数309人)のサッ...

  1. 新型コロナ 両陛下、国民との交流模索 専...
  2. 生きる:小児がん征圧キャンペーン オンラ...
  3. 新型コロナ 両陛下、国民との交流模索 専...
  4. 異変のシグナル:「カネミ油症」救済になお...

ニュース一覧

Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets.

著者 Aguiar PN , De Mello RA , Barreto CMN , Perry LA , Penny-Dimri J , Tadokoro H , Lopes GL
ESMO Open.2017 ; 2(3):e000200.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (3view , 0users)

Full Text Sources

Lung cancer is the leading cause of cancer-related deaths in the world. Immune checkpoint inhibitors (ICI) stimulate cytotoxic lymphocyte activity against tumour cells. These agents are available for the treatment of non-small cell lung cancer (NSCLC) after failure of platinum-based therapy. One recent study has demonstrated that ICI monotherapy was superior to platinum-based chemotherapy for first-line treatment. Nevertheless, this benefit was only for a minority of the population (30%) whose tumour programmed death receptor ligand-1 (PD-L1) expression was above 50%. Therefore, several strategies are under investigation. One option for patients with PD-L1 expression lower than 50% may be the combination of ICI with platinum-based chemotherapy or with ICIs against different targets. However, all of these combinations are at an early stage of investigation and may be very expensive or toxic, producing several harmful adverse events.
PMID: 29209522 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード